Evidence
Cell Mol Life Sci. 2024 Apr 23;81(1):192. doi: 10.1007/s00018-024-05225-z.
ABSTRACT
BACKGROUND: Alzheimer’s disease (AD) is pathologically characterized by the abnormal accumulation of Aβ and tau proteins. There has long been a keen interest among researchers in understanding how Aβ and tau are ultimately cleared in the brain. The discovery of this glymphatic system introduced a novel perspective on protein clearance and it gained recognition as one of the major brain clearance pathways for clearing these pathogenic proteins in AD. This finding has sparked interest in exploring the potential contribution of the glymphatic/meningeal lymphatic system in AD. Furthermore, there is a growing emphasis and discussion regarding the possibility that activating the glymphatic/meningeal lymphatic system could serve as a novel therapeutic strategy against AD.
OBJECTIVES: Given this current research trend, the primary focus of this comprehensive review is to highlight the role of the glymphatic/meningeal lymphatic system in the pathogenesis of AD. The discussion will encompass future research directions and prospects for treatment in relation to the glymphatic/meningeal lymphatic system.
PMID:38652179 | DOI:10.1007/s00018-024-05225-z
Add to Google Keep
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
Involvement of the glymphatic/meningeal lymphatic system in Alzheimer’s disease: insights into proteostasis and future directions
🌐 90 Days
VR Related Evidence Matrix
- Deregulation of the Glymphatic System in Alzheimer's Disease: Genetic and Non-Genetic Factors
- Chronic sleep fragmentation impairs brain interstitial clearance in young wildtype mice
- Human brain clearance imaging: Pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood
- Reduced Diffusivity Along Perivascular Spaces on Magnetic Resonance Imaging Associated with Younger Age of First Use and Cognitive Impairment in Recreational Marijuana Users
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- BV2 Membrane-coated PEGylated-liposomes Delivered hFGF21 to Cortical and Hippocampal Microglia for Alzheimer's Disease Therapy
- Neonatal stress disrupts the glymphatic system development and increases the susceptibility to Parkinson's disease in later life
- Quantifying the Lymphatic Transport of Model Therapeutics from the Brain in Rats
- Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer's Disease
- Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
- Autophagy and exosomes; inter-connected maestros in Alzheimer's disease
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Tau accumulation and its spatial progression across the Alzheimer's disease spectrum
- Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer's astrocytes
- Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
- CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration
- Molecular cross-talk between long COVID-19 and Alzheimer's disease
- Proteomic analysis of P. gingivalis-Lipopolysaccharide induced neuroinflammation in SH-SY5Y and HMC3 cells
- Functional myelin in cognition and neurodevelopmental disorders
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
- Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
- Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- Is Alzheimer disease a disease?
- Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry
- Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World Settings
- Single-molecule imaging of Tau reveals how phosphorylation affects its movement and confinement in living cells
- Disentangling tau: One protein, many therapeutic approaches
- Associations of sleep disorders with all-cause MCI/dementia and different types of dementia - clinical evidence, potential pathomechanisms and treatment options: A narrative review
- MRI index of glymphatic system mediates the influence of locus coeruleus on cognition in Parkinson's disease
- Border-associated macrophages in the central nervous system
- Characterization of cortico-meningeal translocator protein expression in multiple sclerosis
- Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- β-amyloid accumulation enhances microtubule associated protein tau pathology in an APPNL-G-F/MAPTP301S mouse model of Alzheimer's disease
- Insights into amyloid precursor protein target through PPI network analysis
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- Pathogenic soluble tau peptide disrupts endothelial calcium signaling and vasodilation in the brain microvasculature
- Innate immune activation in neurodegenerative diseases
- Disease-Modifying Treatments and Their Future in Alzheimer's Disease Management
- Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model
- Changing landscape in the field of paraneoplastic neurology: Personal perspectives over a 35-year career
- The cytoskeleton adaptor protein Sorbs1 controls the development of lymphatic and venous vessels in zebrafish
- The cytoskeleton adaptor protein Sorbs1 controls the development of lymphatic and venous vessels in zebrafish
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- The Role of Vitamin K in the Development of Neurodegenerative Diseases
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- A multiscale closed-loop neurotoxicity model of Alzheimer's disease progression explains functional connectivity alterations
- Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
- Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission
- Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study
- Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease
- A double inducible cell ablation system for eliminating senescent astrocytes via apoptosis
- Social activity mediates locus coeruleus tangle-related cognition in older adults
- Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome
- Genetic overlap between Alzheimer's disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence
- LRP10 and α-synuclein transmission in Lewy body diseases
Evidence Blueprint
Involvement of the glymphatic/meningeal lymphatic system in Alzheimer’s disease: insights into proteostasis and future directions
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
Save Evidence Blueprint
Save as PDF
Involvement of the glymphatic/meningeal lymphatic system in Alzheimer’s disease: insights into proteostasis and future directions
🌐 365 Days
VR Related Evidence Matrix
- Interplay between the glymphatic system and neurotoxic proteins in Parkinson's disease and related disorders: current knowledge and future directions
- Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation
- Deregulation of the Glymphatic System in Alzheimer's Disease: Genetic and Non-Genetic Factors
- Glymphatic clearance estimated using diffusion tensor imaging along perivascular spaces is reduced after traumatic brain injury and correlates with plasma neurofilament light, a biomarker of injury severity
- Unraveling the lymphatic system in the spinal cord meninges: a critical element in protecting the central nervous system
- Continuous positive airway pressure (CPAP) increases CSF flow and glymphatic transport
- Mistranslation-associated perturbations of proteostasis do not promote accumulation of amyloid beta and plaque deposition in aged mouse brain
- Chronic sleep fragmentation impairs brain interstitial clearance in young wildtype mice
- Human brain clearance imaging: Pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood
- Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
- Reduced Diffusivity Along Perivascular Spaces on Magnetic Resonance Imaging Associated with Younger Age of First Use and Cognitive Impairment in Recreational Marijuana Users
- Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis
- p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- BV2 Membrane-coated PEGylated-liposomes Delivered hFGF21 to Cortical and Hippocampal Microglia for Alzheimer's Disease Therapy
- Imaging of brain barrier inflammation and brain fluid drainage in human neurological diseases
- Unraveling the impact of Omega-3 polyunsaturated fatty acids on blood-brain barrier (BBB) integrity and glymphatic function
- Evaluation of glymphatic system activity using diffusion tensor image analysis along the perivascular space and amyloid PET in older adults with objectively normal cognition: a preliminary study
- Neonatal stress disrupts the glymphatic system development and increases the susceptibility to Parkinson's disease in later life
- Quantifying the Lymphatic Transport of Model Therapeutics from the Brain in Rats
- Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer's Disease
- Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease
- Autophagy and exosomes; inter-connected maestros in Alzheimer's disease
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Tau accumulation and its spatial progression across the Alzheimer's disease spectrum
- Glymphatic system waste clearance and Alzheimer's disease
- New insights into the therapeutic approaches for the treatment of tauopathies
- Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer's astrocytes
- Chronic kidney disease causes blood-brain barrier breakdown via urea-activated matrix metalloproteinase-2 and insolubility of tau protein
- Relationship between the tau protein and choroid plexus volume in Alzheimer's disease
- Biochemical approaches to assess the impact of post-translational modifications on pathogenic tau conformations using recombinant protein
- CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration
- Molecular cross-talk between long COVID-19 and Alzheimer's disease
- Proteomic analysis of P. gingivalis-Lipopolysaccharide induced neuroinflammation in SH-SY5Y and HMC3 cells
- Spatial transcriptomic patterns underlying amyloid-β and tau pathology are associated with cognitive dysfunction in Alzheimer's disease
- Preserved autophagy in cognitively intact non-demented individuals with Alzheimer's neuropathology
- Functional myelin in cognition and neurodevelopmental disorders
- Vascular risk factors and astrocytic marker for the glymphatic system activity
- Mutant α-synuclein propagates via the lymphatic system of the brain in the monomeric state
- Exposure to low-intensity blast increases clearance of brain Aβ
- Primary Hypothyroidism and Alzheimer's Disease: A Tale of Two
- Localized proteomic differences in the choroid plexus of Alzheimer's disease and epilepsy patients
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
- Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease
- Impact of Sleep Disorders and Disturbed Sleep on Brain Health: A Scientific Statement From the American Heart Association
- Detection, visualization and quantification of protein complexes in human Alzheimer's disease brains using proximity ligation assay
- Uncovering the Significance of STEP61 in Alzheimer's Disease: Structure, Substrates, and Interactome
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
- Gray Matter Reserve Determines Glymphatic System Function in Young-Onset Alzheimer's Disease: Evidenced by DTI-ALPS and Compared with Age-matched Controls
- Tau and Alzheimer's disease: Past, present and future
- The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies
- The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
- Advancements in investigating the role of cerebral small vein loss in Alzheimer's disease-related pathological changes
- Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury
- The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome
- Investigating neural dysfunction with abnormal protein deposition in Alzheimer's disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography
- Is Alzheimer disease a disease?
- A data-driven study of Alzheimer's disease related amyloid and tau pathology progression